ZA951781B - Pharmaceutical formulations - Google Patents

Pharmaceutical formulations

Info

Publication number
ZA951781B
ZA951781B ZA951781A ZA951781A ZA951781B ZA 951781 B ZA951781 B ZA 951781B ZA 951781 A ZA951781 A ZA 951781A ZA 951781 A ZA951781 A ZA 951781A ZA 951781 B ZA951781 B ZA 951781B
Authority
ZA
South Africa
Prior art keywords
pharmaceutical formulations
formulations
pharmaceutical
Prior art date
Application number
ZA951781A
Inventor
Meena Aggarwal
John Neville Hague
Karrar Ahmad Khan
Alan Smith
Original Assignee
Boots Co Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boots Co Plc filed Critical Boots Co Plc
Publication of ZA951781B publication Critical patent/ZA951781B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
ZA951781A 1994-03-05 1995-03-03 Pharmaceutical formulations ZA951781B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9404248A GB9404248D0 (en) 1994-03-05 1994-03-05 Pharmaceutical formulations

Publications (1)

Publication Number Publication Date
ZA951781B true ZA951781B (en) 1995-09-05

Family

ID=10751332

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA951781A ZA951781B (en) 1994-03-05 1995-03-03 Pharmaceutical formulations

Country Status (10)

Country Link
EP (1) EP0749301A1 (en)
JP (1) JPH09509675A (en)
AU (1) AU691583B2 (en)
CZ (1) CZ258596A3 (en)
GB (1) GB9404248D0 (en)
NZ (1) NZ281633A (en)
PL (1) PL316040A1 (en)
SK (1) SK113296A3 (en)
WO (1) WO1995023596A1 (en)
ZA (1) ZA951781B (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0858805A3 (en) * 1997-02-13 1998-09-02 National Research Institute of Chinese Medicine Transdermal preparations of oxicams
ES2275525T3 (en) 1999-07-12 2007-06-16 Capnia Incorporated APPLIANCE TO RELIEF HEAD PAIN, RHINITIS AND OTHER COMMON AFFECTIONS
US20070039615A1 (en) 1999-11-08 2007-02-22 Capnia, Incorporated Methods and apparatus for treating rhinitis
US20060172017A1 (en) 1999-11-08 2006-08-03 Capnia, Incorporated Methods and apparatus for the enhanced delivery of physiologic agents to tissue surfaces
US20190328679A1 (en) 2001-10-12 2019-10-31 Aquestive Therapeutics, Inc. Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US10285910B2 (en) 2001-10-12 2019-05-14 Aquestive Therapeutics, Inc. Sublingual and buccal film compositions
US8765167B2 (en) 2001-10-12 2014-07-01 Monosol Rx, Llc Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US7357891B2 (en) 2001-10-12 2008-04-15 Monosol Rx, Llc Process for making an ingestible film
US11207805B2 (en) 2001-10-12 2021-12-28 Aquestive Therapeutics, Inc. Process for manufacturing a resulting pharmaceutical film
US8603514B2 (en) 2002-04-11 2013-12-10 Monosol Rx, Llc Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
US20110033542A1 (en) 2009-08-07 2011-02-10 Monosol Rx, Llc Sublingual and buccal film compositions
US7927613B2 (en) 2002-02-15 2011-04-19 University Of South Florida Pharmaceutical co-crystal compositions
US20050025791A1 (en) * 2002-06-21 2005-02-03 Julius Remenar Pharmaceutical compositions with improved dissolution
WO2004060347A2 (en) * 2002-09-03 2004-07-22 Transform Pharmaceuticals, Inc. Pharmaceutical propylene glycol solvate compositions
AU2003213719A1 (en) 2002-03-01 2003-09-16 Regents Of The University Of Michigan Multiple-component solid phases containing at least one active pharmaceutical ingredient
GB0518769D0 (en) * 2005-09-14 2005-10-19 Medpharm Ltd Topical formulations
HU227970B1 (en) 2007-07-10 2012-07-30 Egis Gyogyszergyar Nyrt Pharmaceutical compositions containing silicones of high volatility
CN102196821A (en) * 2008-10-31 2011-09-21 莫贝里德尔马公司 Topical composition comprising a combination of at least two penetration enhancing agents
TR200907179A1 (en) 2009-09-18 2011-04-21 Sanovel İlaç San. Ve Ti̇c. A. Ş. Flurbiprofen and muscle relaxant combinations
US9149959B2 (en) 2010-10-22 2015-10-06 Monosol Rx, Llc Manufacturing of small film strips
EP2468270A1 (en) * 2010-12-21 2012-06-27 GALENpharma GmbH (R)-2-(3-fluoro-4-phenylphenyl)propionic acid for use in the treatment of skin diseases
ME03540B (en) * 2011-05-03 2020-07-20 Aponia Laboratories Inc Transdermal compositions of ibuprofen and methods of use thereof
WO2013095318A2 (en) 2011-12-23 2013-06-27 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Orally-disintegrating formulations of flurbiprofen
US20140322338A1 (en) 2011-12-23 2014-10-30 Sanovel IIac Sanayi Ve Ticaret Anonim Sirketi Flurbiprofen formulations
US20140377343A1 (en) 2011-12-23 2014-12-25 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Formulations of flurbiprofen and diacerein
US11154535B2 (en) 2012-07-31 2021-10-26 Egis Pharmaceuticals Plc Transdermal formulation containing COX inhibitors
US10045935B2 (en) 2012-07-31 2018-08-14 Egis Pharmaceuticals Plc Transdermal formulation containing COX inhibitors
US10596117B1 (en) 2014-12-31 2020-03-24 Eric Morrison Lipoleosomes as carriers for aromatic amide anesthetic compounds
US11007161B1 (en) 2014-12-31 2021-05-18 Eric Morrison Ibuprofen nanoparticle carriers encapsulated with hermatic surfactant films
US10561627B2 (en) 2014-12-31 2020-02-18 Eric Morrison Ibuprofen nanoparticle carriers encapsulated with hermetic surfactant films
US11273131B2 (en) 2016-05-05 2022-03-15 Aquestive Therapeutics, Inc. Pharmaceutical compositions with enhanced permeation
KR20190005199A (en) 2016-05-05 2019-01-15 어퀘스티브 테라퓨틱스, 아이엔씨. Enhanced delivery fffffrin composition
CA3085488A1 (en) * 2017-12-11 2019-06-20 Meat & Livestock Australia Ltd Transdermal analgesic formulation
ES2835399B2 (en) * 2019-12-20 2022-03-23 Univ Jaen Procedure for obtaining a textile material carrying molecules of pharmacological interest and material thus obtained

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB119646A (en) * 1917-10-05 1919-07-04 Hendrik Johannes Chr Hengeveld Wadding for Curing Rheumatism.
GB1191646A (en) * 1966-10-05 1970-05-13 American Gage & Mach Recording Apparatus
GB2075837B (en) * 1980-05-14 1984-03-14 Hisamitsu Pharmaceutical Co Topical pharmaceutical gel containing anti-inflammatory analgesic agents
JPS57140711A (en) * 1981-02-26 1982-08-31 Teika Seiyaku Kk Poultice for anti-inflammatory and analgesic use and its preparation
JPH0662401B2 (en) * 1985-04-25 1994-08-17 久光製薬株式会社 Ketoprofen-containing patch
DE3522550A1 (en) * 1985-06-24 1987-01-02 Klinge Co Chem Pharm Fab SPRAYABLE PHARMACEUTICAL PREPARATION FOR TOPICAL APPLICATION
JPS6399866A (en) * 1986-10-17 1988-05-02 石田 賢司 Lint cloth having drug coated surface and its production
JP2570342B2 (en) * 1987-12-01 1997-01-08 日産化学工業株式会社 External solution
CA1331137C (en) * 1988-02-29 1994-08-02 Pfizer, Inc. Transdermal flux enhancing compositions
US5061724A (en) * 1989-07-18 1991-10-29 Sheldon Gertner Method for treating arthritically inflamed body joints, particularly joints having gouty arthritis
US5093133A (en) * 1990-01-24 1992-03-03 Mcneil-Ppc, Inc. Method for percutaneous delivery of ibuprofen using hydroalcoholic gel
WO1992005768A1 (en) * 1990-10-05 1992-04-16 Analgesic Associates Prevention or treatment of sunburn using the s(+) isomer of flurbiprofen
JPH1143831A (en) * 1997-07-22 1999-02-16 Murata Mach Ltd Spinning device

Also Published As

Publication number Publication date
WO1995023596A1 (en) 1995-09-08
NZ281633A (en) 1998-04-27
AU1850295A (en) 1995-09-18
SK113296A3 (en) 1997-05-07
EP0749301A1 (en) 1996-12-27
CZ258596A3 (en) 1996-12-11
AU691583B2 (en) 1998-05-21
PL316040A1 (en) 1996-12-23
GB9404248D0 (en) 1994-04-20
JPH09509675A (en) 1997-09-30

Similar Documents

Publication Publication Date Title
ZA953236B (en) Pharmaceutical formulations
EG23826A (en) Pharmaceutical formulations
ZA951781B (en) Pharmaceutical formulations
GB9523752D0 (en) Pharmaceutical formulations
GB9407386D0 (en) Pharmaceutical formulation
GB9402203D0 (en) Pharmaceutical formulation
IL112521A0 (en) Pharmaceutical formulation
GB9405856D0 (en) Pharmaceutical formulation
GB9416599D0 (en) Pharmaceutical formulation
GB9408053D0 (en) Pharmaceutical preparation
GB9311030D0 (en) Pharmaceutical formulations
GB9323399D0 (en) Pharmaceutical formulations
ZA96392B (en) Pharmaceutical formulations
GB9413542D0 (en) Pharmaceutical formulations
GB9500978D0 (en) Pharmaceutical formulations
GB9417953D0 (en) Pharmaceutical formulations
GB9408151D0 (en) Pharmaceutical formulations
GB9408162D0 (en) Pharmaceutical formulations
GB9408161D0 (en) Pharmaceutical formulations
GB9401738D0 (en) Pharmaceutical formulations
GB9408163D0 (en) Pharmaceutical formulations
GB9426113D0 (en) Pharmaceutical formulations
GB9408164D0 (en) Pharmaceutical formulations
GB9414216D0 (en) Pharmaceutical formulations
GB9621531D0 (en) Pharmaceutical formulations